EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment

Shane Whelan iD, Brigid Lucey, Karen Finn iD

Microorganisms · 28.08.2023 · 11 (9) · 2169

DOI: 10.3390/microorganisms11092169 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 28.08.2023. Verfasst von Shane Whelan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Munster Technological University, Bishopstown, T12 P928 Cork, Ireland. Die Arbeit wurde bisher 186-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Munster Technological University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections (UTIs) are among the most common bacterial infections, especially among women and older adults, leading to a significant global healthcare cost burden. Uropathogenic Escherichia coli (UPEC) are the most common cause and accounts for the majority of community-acquired UTIs. Infection by UPEC can cause discomfort, polyuria, and fever. More serious clinical consequences can result in urosepsis, kidney damage, and death. UPEC is a highly adaptive pathogen which presents significant treatment challenges rooted in a complex interplay of molecular factors that allow UPEC to evade host defences, persist within the urinary tract, and resist antibiotic therapy. This review discusses these factors, which include the key genes responsible for adhesion, toxin production, and iron acquisition. Additionally, it addresses antibiotic resistance mechanisms, including chromosomal gene mutations, antibiotic deactivating enzymes, drug efflux, and the role of mobile genetic elements in their dissemination. Furthermore, we provide a forward-looking analysis of emerging alternative therapies, such as phage therapy, nano-formulations, and interventions based on nanomaterials, as well as vaccines and strategies for immunomodulation. This review underscores the continued need for research into the molecular basis of pathogenesis and antimicrobial resistance in the treatment of UPEC, as well as the need for clinically guided treatment of UTIs, particularly in light of the rapid spread of multidrug resistance.

Schlagwörter

Stichwörter der Autor:innen

antibiotic resistancebiofilm formationmobile genetic elementsuropathogenic E. coli

Autor:innen und Institutionen

  • Department of Biological Sciences, Munster Technological University, Bishopstown, T12 P928 Cork, Ireland.
  • Department of Analytical, Biopharmaceutical and Medical Sciences, Atlantic Technological University Galway City, Dublin Road, H91 T8NW Galway, Ireland.

ORCID-Profile: Shane Whelan, Karen Finn

Förderung

  • Munster Technological University

Zitieren

APA

Whelan, S., Lucey, B., & Finn, K. (2023). Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment. Microorganisms, 11(9), 2169. https://doi.org/10.3390/microorganisms11092169

Vancouver

Whelan S, Lucey B, Finn K. Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment. Microorganisms. 2023;11(9):2169. doi:10.3390/microorganisms11092169

BibTeX
@article{Whelan2023,
  author = {Whelan, Shane and Lucey, Brigid and Finn, Karen},
  title = {Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment},
  journal = {Microorganisms},
  year = {2023},
  volume = {11},
  number = {9},
  pages = {2169},
  doi = {10.3390/microorganisms11092169}
}
Kostenlos starten →